ADENOCARCINOMA OF THE PROSTATE
Clinical trials for ADENOCARCINOMA OF THE PROSTATE explained in plain language.
Never miss a new study
Get alerted when new ADENOCARCINOMA OF THE PROSTATE trials appear
Sign up with your email to follow new studies for ADENOCARCINOMA OF THE PROSTATE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Precision proton beams take aim at High-Risk prostate tumors
Disease control OngoingThis study tests whether a higher dose of proton radiation, focused on tumors seen on MRI, can better control high-risk prostate cancer. About 100 participants will receive radiation over 8-9 weeks, plus hormone therapy for 18 months. The goal is to lower the chance of cancer ret…
Matched conditions: ADENOCARCINOMA OF THE PROSTATE
Phase: PHASE2 • Sponsor: University of Florida • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
High-dose radiation aims to control tough prostate cancer
Disease control OngoingThis study tests a special type of radiation called stereotactic body radiotherapy (SBRT) for men with high-risk prostate cancer that hasn't spread. The treatment delivers a strong, focused dose of radiation to the tumor to kill cancer cells while sparing healthy tissue. Research…
Matched conditions: ADENOCARCINOMA OF THE PROSTATE
Phase: NA • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New adaptive therapy aims to outsmart prostate cancer
Disease control OngoingThis early-phase trial tests an adaptive approach to hormone therapy for men with stage IV prostate cancer that still responds to hormone treatment. Instead of a fixed schedule, the treatment is adjusted based on PSA levels. The study includes 17 participants and combines standar…
Matched conditions: ADENOCARCINOMA OF THE PROSTATE
Phase: EARLY_PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Triple therapy shows promise for aggressive prostate cancer
Disease control OngoingThis early-phase study tested a combination of enzalutamide (a hormone-blocking drug), radiation therapy, and standard hormone therapy in 25 men with intermediate or high-risk prostate cancer. The main goal was to check for side effects and find the best way to give the treatment…
Matched conditions: ADENOCARCINOMA OF THE PROSTATE
Phase: PHASE1 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New radiation cocktail aims to cut prostate cancer treatment time
Disease control OngoingThis phase 1 trial tests a combination of two radiation techniques for men with intermediate risk prostate cancer. First, a high dose of radiation is placed inside the prostate for 10-20 minutes (brachytherapy), followed by three weeks of highly targeted external radiation (SBRT)…
Matched conditions: ADENOCARCINOMA OF THE PROSTATE
Phase: PHASE1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Jun 26, 2026 16:10 UTC